SCHEMBL6310683

SCHEMBL6310683

Cc1nc(-c2c(C)c(C#N)c3nc4ccccn4c3c2Cl)cs1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.36
GAA P10253 6/20 0.36
ALDH1A1 P00352 6/20 0.32
LMNA P02545 3/20 0.32
MAPT P10636 3/20 0.32
HTT P42858 3/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
NPSR1 Q6W5P4 3/20 0.32
HPGD P15428 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ALOX12 P18054 1/20 0.32
HSD17B10 Q99714 2/20 0.32
MAPK1 P28482 1/20 0.32
PRKD3 O94806 1/20 0.31
MAP4K4 O95819 1/20 0.31
PIM1 P11309 1/20 0.31
RPS6KB1 P23443 1/20 0.31
CDK2 P24941 1/20 0.31
FLT4 P35916 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6311782 0.88 KDM4E (0.34) KDM4EGAAALDH1A1LMNAMAPT
SCHEMBL6311027 0.88 SREBF2 (0.38) KDM4EALDH1A1MAPTHTTSMN1; SMN2
SCHEMBL6310367 0.82 HTT (0.43) KDM4EALDH1A1LMNAHTTSMN1; SMN2
SCHEMBL6311042 0.82 KDM4E (0.45) KDM4EGAAALDH1A1MAPTHTT
SCHEMBL6319505 0.81 KDM4E (0.34) KDM4EGAAALDH1A1HTTHPGD
SCHEMBL6312786 0.81 KDM4E (0.44) KDM4EGAAALDH1A1LMNAMAPT
SCHEMBL6311468 0.78 HPGD (0.45) KDM4EGAAALDH1A1LMNAMAPT
SCHEMBL6309849 0.78 KDM4E (0.41) KDM4EGAAALDH1A1MAPTNPSR1
SCHEMBL6312626 0.76 PIK3CD (0.45) KDM4EGAAALDH1A1HTTNPSR1
SCHEMBL6310328 0.76 NPSR1 (0.44) KDM4EGAAALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 KDM4E 3360/4885GAA 58/4885ALDH1A1 2550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.